Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1

Nature

Volumn 446, Issue 7136, 2007, Pages 685-689

  Ono, Masahiro ^a,b   Yaguchi, Hiroko ^c   Ohkura, Naganari ^c   Kitabayashi, Issay ^c   Nagamura, Yuko ^c   Nomura, Takashi ^a   Miyachi, Yoshiki ^b   Tsukada, Toshihiko ^c   Sakaguchi, Shimon ^a,d  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; NATURAL KILLER CELL RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR RUNX1;

ANTIGEN; GENE EXPRESSION; HOMEOSTASIS; IMMUNE RESPONSE; PROTEIN;

ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; MOLECULAR INTERACTION; MOLECULAR MODEL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; UPREGULATION;

EID: 34247215187     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature05673     Document Type: Article

References (28)

1. Shevach, E. M. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18, 423-449 (2000).
2. Maloy, K. J. & Powrie, F. Regulatory T cells in the control of immune pathology. Nature Immunol. 2, 816-822 (2001).
3. + regulatory T cells for immunologic selftolerance and negative control of immune responses. Annu. Rev. Immunol. 22, 531-562 (2004).
4. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
5. + regulatory T cells. Nature Immunol. 4, 330-336 (2003).
6. + T regulatory cells. Nature Immunol. 4, 337-342 (2003).
7. Fontenot, J. D., Rasmussen, J. P., Gavin, M. A. & Rudensky, A. Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nature Immunol. 6, 1142-1151 (2005).
8. Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G. & Downing, J. R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84, 321-330 (1996).
9. Wang, Q. et al. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc. Natl Acad. Sci. USA 93, 3444-3449 (1996).
10. Taniuchi, I. et al. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 111, 621-633 (2002).
11. + T cells into the Th2 lineage by repressing GATA3 expression. J. Exp. Med. 198, 51-61 (2003).
12. Jain, J., Loh, C. & Rao, A. Transcriptional regulation of the IL-2 gene. Curr. Opin. Immunol. 7, 333-342 (1995).
13. Rooney, J. W., Sun, Y. L., Glimcher, L. H. & Hoey, T. Novel NFAT sites that mediate activation of the interleukin-2 promoter in response to T-cell receptor stimulation. Mol. Cell. Biol. 15, 6299-6310 (1995).
14. Bruniquel, D. & Schwartz, R. H. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nature Immunol. 4, 235-240 (2003).
15. Novak, T. J., White, P. M. & Rothenberg, E. V. Regulatory anatomy of the murine interleukin-2 gene. Nucleic Acids Res. 18, 4523-4533 (1990).
16. Kitabayashi, I., Yokoyama, A., Shimizu, K. & Ohki, M. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J. 17, 2994-3004 (1998).
17. + regulatory T cells. Int. Immunol. 16, 1643-1656 (2004).
18. - T cells. J. Clin. Invest. 112, 1437-1443 (2003).
19. Fontenot, J. D. et al. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22, 329-341 (2005).
20. - regulatory T cells. J. Immunol. 176, 4748-4756 (2006).
21. Kanno, Y., Kanno, T., Sakakura, C., Bae, S. C. &Ito, Y. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor α (CBFα) subunit by the leukemia-related PEBP2/CBFβ-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation. Mol. Cell. Biol. 18, 4252-4261 (1998).
22. Wu, Y. et al. FOXP3 controls regulatory T cell function through cooperation with NFAT. Cell 126, 375-387 (2006).
23. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296 (1998).
24. + naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol. 10, 1969-1980 (1998).
25. Brenner, O. et al. Loss of Runx3 function in leukocytes is associated with spontaneously developed colitis and gastric mucosal hyperplasia. Proc. Natl Acad. Sci. USA 101, 16016-16021 (2004).
26. Prokunina, L. et al. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nature Genet. 32, 666-669 (2002).
27. Helms, C. et al. A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis. Nature Genet. 35, 349-356 (2003).
28. Tokuhiro, S. et al. An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nature Genet. 35, 341-348 (2003).